عالم الاخبار عالم الاخبار

Moderna's COVID-19 vaccine shows positive results, moves to larger studies




A COVID-19 vaccine candidate has shown it can prompt an immune response in the human body, and was also found to be safe and well-tolerated in a small group of patients.

Moderna, a Cambridge, Massachusetts-based company that manufactured the vaccine, announced the encouraging early results from its phase 1 clinical trial Monday morning. The drug is now being tested in larger studies.

Full coverage of the coronavirus outbreak

The phase 1 trial involved 45 people. Results on eight of those participants revealed they developed neutralizing antibodies — which are believed to be key in providing protection from the virus — at levels seen in patients who've recovered from COVID-19.

"We could not be happier about this interim data," Moderna CEO Stéphane Bancel said during a conference call with investors Monday. He said the results indicate the vaccine has a "high probability to provide protection from COVID-19 disease in humans."

التعليقات



إذا أعجبك محتوى مدونتنا نتمنى البقاء على تواصل دائم ، فقط قم بإدخال بريدك الإلكتروني للإشتراك في بريد المدونة السريع ليصلك جديد المدونة أولاً بأول ، كما يمكنك إرسال رساله بالضغط على الزر المجاور ...

إتصل بنا

جميع الحقوق محفوظة

عالم الاخبار

2016